Safety Observer

May 2024

Safety Observer 211

CIOMS has published a new draft report on Severe Cutaneous Adverse Reactions (SCARs).

Released 06-May-2024
Pages 36
Subscribe Highlights

Report 211 — Highlights

CIOMS: SCARs

CIOMS has published a new draft report on Severe Cutaneous Adverse Reactions (SCARs), which covers various aspects including diagnosis and causality assessment.

EMA: New RWE guidance

The EMA has published a couple of guidance documents regarding the use of RWE, which includes a draft reflection paper on the use of RWD in non-interventional studies to generate RWE.

EMA: Reproduction and Lactation

The EMA has published a new concept paper on a proposal to revise the 2008 Guideline on “Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labelling”.

MHRA & E2B(R3)

The MHRA has published new information on the submission of ICSRs, which describes the plans for the implementation of the ICH E2B(R3) standard in the MHRA database and its impact.

Swissmedic & E2B(R3)

Swissmedic has also published a note to inform MAHs about the plans for the migration of their ICSR submission systems to the E2B(R3) format.

Sign up for alerts

Receive alerts and news on pharmacovigilance regulatory requirements every month.

Register today!

Safety Observer

EUR (€)
My account

Social

3-Month Plan

This Plan includes three consecutive reports starting with the next release. The perfect solution to test the value of our service.

Starts at 180 

1-Year Plan

This Plan includes eleven consecutive reports starting with the next release. Includes a double issue for July/August.

Starts at 600 

Stay in the loop

Join over 1,000 Pharmacovigilance professionals and receive our Free Content straight to your mailbox !